Halozyme Therapeutics Inc (HALO)
45.73
-0.03
(-0.07%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.09
(+0.20%)
After-Hours: 20:00
Halozyme Therapeutics Gross Profit Margin (Quarterly): 82.96% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 82.96% |
| June 30, 2024 | 82.88% |
| March 31, 2024 | 85.54% |
| December 31, 2023 | 77.27% |
| September 30, 2023 | 74.62% |
| June 30, 2023 | 77.35% |
| March 31, 2023 | 78.31% |
| December 31, 2022 | 76.79% |
| September 30, 2022 | 77.36% |
| June 30, 2022 | 77.72% |
| March 31, 2022 | 86.42% |
| December 31, 2021 | 78.84% |
| September 30, 2021 | 83.95% |
| June 30, 2021 | 83.13% |
| March 31, 2021 | 79.53% |
| December 31, 2020 | 78.41% |
| September 30, 2020 | 91.48% |
| June 30, 2020 | 89.61% |
| March 31, 2020 | 77.18% |
| December 31, 2019 | 68.91% |
| September 30, 2019 | 51.69% |
| June 30, 2019 | 95.21% |
| March 31, 2019 | 91.84% |
| December 31, 2018 | 90.67% |
| September 30, 2018 | 97.55% |
| Date | Value |
|---|---|
| June 30, 2018 | 97.63% |
| March 31, 2018 | 90.11% |
| December 31, 2017 | 96.05% |
| September 30, 2017 | 86.93% |
| June 30, 2017 | 76.92% |
| March 31, 2017 | 74.49% |
| December 31, 2016 | 79.48% |
| September 30, 2016 | 71.32% |
| June 30, 2016 | 75.08% |
| March 31, 2016 | 81.74% |
| December 31, 2015 | 83.86% |
| September 30, 2015 | 70.26% |
| June 30, 2015 | 81.23% |
| March 31, 2015 | 65.21% |
| December 31, 2014 | 79.76% |
| September 30, 2014 | 64.80% |
| June 30, 2014 | 67.78% |
| March 31, 2014 | 53.87% |
| December 31, 2013 | 71.68% |
| September 30, 2013 | 95.73% |
| June 30, 2013 | 91.12% |
| March 31, 2013 | 93.76% |
| December 31, 2012 | 97.00% |
| September 30, 2012 | 95.75% |
| June 30, 2012 | 98.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
68.91%
Minimum
Dec 2019
91.48%
Maximum
Sep 2020
80.41%
Average
78.62%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.83% |
| Novavax Inc | 28.27% |
| Insulet Corp | 69.33% |
| BioLife Solutions Inc | 53.30% |
| TransMedics Group Inc | 55.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 156.6% |
| Return on Assets | 20.54% |
| Return on Invested Capital | 22.41% |
| Profit Margin (Quarterly) | 47.23% |
| Operating Margin (Quarterly) | 56.26% |
| Return on Net Operating Assets | 29.73% |